Lessee, Operating Lease, Liability, to be Paid in USD of Unity Biotechnology, Inc. from Q1 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Unity Biotechnology, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q1 2020 to Q1 2025.
  • Unity Biotechnology, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2025 was $26M, a 16.1% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $26M -$5M -16.1% Mar 31, 2025 10-Q 2025-04-22
Q4 2024 $27.3M -$4.96M -15.4% Dec 31, 2024 10-K 2025-03-07
Q3 2024 $28.6M -$4.93M -14.7% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $29.8M -$4.89M -14.1% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $31M -$4.85M -13.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $32.3M -$4.81M -13% Dec 31, 2023 10-K 2024-04-15
Q3 2023 $33.5M -$4.77M -12.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $34.7M -$5.27M -13.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $35.9M -$5.78M -13.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $37.1M -$6.29M -14.5% Dec 31, 2022 10-K 2023-03-15
Q3 2022 $38.3M -$6.79M -15.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $39.9M -$6.76M -14.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $41.7M -$6.7M -13.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $43.4M -$6.65M -13.3% Dec 31, 2021 10-K 2022-03-15
Q3 2021 $45M -$6.6M -12.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $46.7M -$6.55M -12.3% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $48.4M -$6.61M -12% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $50M Dec 31, 2020 10-K 2021-03-23
Q3 2020 $51.6M Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $53.3M Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $55M Mar 31, 2020 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.